Literature DB >> 8045475

Interaction of 14C-labelled fumonisin B mycotoxins with primary rat hepatocyte cultures.

M E Cawood1, W C Gelderblom, J F Alberts, S D Snyman.   

Abstract

An in vitro study on the interaction and biotransformation of the [14C]fumonisin B mycotoxins was conducted, using primary rat hepatocyte cultures and subcellular enzyme preparations. At the same concentration, fumonisin B2 (FB2) exhibited a higher cytotoxicity and specific binding to primary rat hepatocytes than fumonisin B1 (FB1). However, if the effective dose level (EDL) is considered (i.e. the lowest level of toxin that binds to the hepatocytes to elicit a cytotoxic effect), FB1 and FB2 exhibited a similar cytotoxic effect. FB1 was found to be associated with both the soluble and insoluble compartments within the cell. As assessed by the radioactivity associated with the cellular preparations, very little (approximately 0.01%) FB1 and/or FB2 bound to hepatocytes. In the subsequent fractionation of the culture medium using amberlite XAD-2 and silica-gel chromatography, no metabolites were detected, indicating that the fumonisin molecule was not metabolized by primary hepatocytes. The latter aspect was confirmed by the fact that incubation of FB1 with microsomal enzyme preparations also failed to indicate any metabolism of the fumonisins by the esterases or by cytochrome P-450 monooxygenase. FB1 was also found not to be a substrate for the triglyceride hepatic endothelial lipase, nor for a lipase from porcine pancreas. This study supports further the hypothesis that the intact molecule of the fumonisins is required for biological activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045475     DOI: 10.1016/0278-6915(94)90006-x

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  Fumonisin B1 metabolism by bovine liver microsomes.

Authors:  M Spotti; G Pompa; F Caloni
Journal:  Vet Res Commun       Date:  2001-08       Impact factor: 2.459

2.  Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.

Authors:  W C A Gelderblom; W Moritz; S Swanevelder; C M Smuts; S Abel
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

3.  In vitro and in vivo studies to assess the effectiveness of cholestyramine as a binding agent for fumonisins.

Authors:  M Solfrizzo; A Visconti; G Avantaggiato; A Torres; S Chulze
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

4.  The effect of fumonisin B1 on developing chick embryos: correlation between de novo sphingolipid biosynthesis and gross morphological changes.

Authors:  C Zacharias; G van Echten-Deckert; E Wang; A H Merrill; K Sandhoff
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

Review 5.  Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion.

Authors:  W C Gelderblom; S Abel; C M Smuts; J Marnewick; W F Marasas; E R Lemmer; D Ramljak
Journal:  Environ Health Perspect       Date:  2001-05       Impact factor: 9.031

6.  Cytotoxicity of fumonisin B1, diethylnitrosamine, and catechol on the SNO esophageal cancer cell line.

Authors:  Rene B Myburg; Michael F Dutton; Anil A Chuturgoon
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.